The market’s recent sharp rotation has been the main story for traders over the past couple of weeks, with capital moving away from many of the year’s biggest AI winners and into areas that had previously lagged. Healthcare has emerged as one of the strongest beneficiaries of that shift, and one name that continues to separate itself is Johnson & Johnson (JNJ). After an early-year advance was interrupted by the geopolitical uncertainty surrounding the Iran conflict, the stock spent weeks holding a tight trading range instead of breaking down, quietly building a solid base. That patience is now being rewarded as JNJ has broken out to fresh highs, while its Chaikin Money Flow (CMF) has turned strongly positive and is accelerating higher—an encouraging sign that both institutional and retail buyers are aggressively accumulating shares as money rotates into new leadership.

📈 Wall Street is picking new leaders—are you still chasing the old ones? Join us live this Tuesday to see the trades we’re watching now. 💡

While the breakout is technically impressive, the stock has also covered a lot of ground over the past week and a half, making it reasonable to wait for a modest pullback before considering an entry. A retracement toward the rising 20-day moving average followed by renewed buying pressure would present a cleaner, more disciplined setup in our view. I would look to participate by purchasing shares, though an in-the-money call option may offer a more capital-efficient way to gain bullish exposure. Under one currently available option setup, if JNJ were to rally another 10% by expiration, the position would be on pace for approximately a 125.1% return, though outcomes will always depend on both price movement and time remaining until expiration.

If you’re looking for a proven process to uncover high-quality trade setups before they become headlines on CNBC, the Optioneering Newsletter was built for exactly that purpose. Start your first month for just $1 and see the technical analysis, trade logic, and specific options strategies our team is using to pursue some of the market’s most compelling opportunities. Click here to begin your $1 trial today.

Wishing You the Best in Investing Success,

Blane Markham

Chief Trading Strategist

Have any questions? Email us at support@markhamtrading.com

*Trading incurs risk and some people lose money trading.